This profile was last updated on 3/18/13
and contains information from public web pages.
|
Dr. Herbert T. NagasawaWrong Dr. Herbert T. Nagasawa?Co-Founder, Chairman and Director...
GQqK-r2p6Col__VdZgNdGQ
Max International LLC
6965 South Union Park Center Suite 100 Salt Lake City, Utah 84047 United States
Company Description: Max International was founded by dedicated and successful entrepreneurs and executives who had a vision. After meeting with Dr. Keller and learning about MaxGXL...
more
|
|
Background
Employment History
-
Executive Research Scientist
Max International LLC
-
Principal Scientist
VA Medical Center
-
Senior Chemist
VA Medical Center
-
Member, Research Staff
VA Medical Center
-
Assistant Professor of Medicinal Chemistry
University of Minnesota
-
Professor of Medicinal Chemistry and Toxicology
University of Minnesota
-
Senior Editor
Medicinal Chemistry
-
Chief Scientist and Co-Founder
Cellgevity , Inc.
-
Chairman and Director of Research
Cellgevity , Inc.
-
Visiting Professor
Washington State University
-
Editorial Board
Bioconjugate Chemistry
-
Ad Hoc Grant Reviewer
NCI
Board Memberships and Affiliations
-
Post-doctoral Fellow In Biochemistry
University of Minnesota
Education
-
Ph.D.
-
B.S. degree , chemistry
Western Reserve University
-
National Institutes of Health-Homeland Security 4th Annual Countermeasures Against Chemical Threats Network Symposium
-
National Institutes of Health-Homeland Security 4th Annual Countermeasures Against Chemical Threats Network Symposium
75 Total References
Web References
Max International
max4u.com, 18 Mar 2013 [cached]Although Max was founded only in 2007, our growing expertise is based on more than 25 years of research performed by Dr. Herbert Nagasawa, who joined Max in 2009.
Dr. Herbert T. Nagasawa, Executive Research Scientist
Dr. Nagasawa received his B.S. degree in chemistry from Western Reserve University (now, Case-Western Reserve) in Cleveland, Ohio, and a Ph.D. degree in organic chemistry from the University of Minnesota.
Subsequently, he spent two years as a Post-doctoral Fellow in biochemistry at the University of Minnesota before joining the research staff of the V.A. Medical Center in Minneapolis as a Senior Chemist.
He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959.He was named Principal Scientist of the VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA's top scientists.He was promoted to Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973.He also held joint professorships in the Department of Pharmacology and the university-wide Division of Toxicology, and served as Visiting Professor at Washington State University in 1990.He also served for 32 years as a Senior Editor for the prestigious international Journal of Medicinal Chemistry from 1972 to 2004, and one year as Acting Editor-in-Chief.In addition, he served on the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health.
He has published over 165 papers in peer-reviewed journals.
In June of 2010, Herb attended the National Institutes of Health-Homeland Security 4th Annual Countermeasures Against Chemical Threats Network Symposium held in San Francisco.
Herb and the team of scientists presented their work on the cyanide antidote.
Scott, an original co-founder of CellGevity, then left to join Dr. Herb Nagasawa and Scott Momii at CellGevity, and served full-time as the Chief Technical Officer (CTO).
max4u.com, 18 Mar 2013 [cached]
...
...
TheMax4uStore MaxGXL - Max GXL
www.themax4ustore.com, 23 Feb 2013 [cached]
www.themax4ustore.com, 23 Feb 2013 [cached]
We are very excited to announce that Max International has acquired the technology and assets behind CellGevity, a company founded in part by Dr. Herbert Nagasawa after 40 years of scientific research on Glutathione and the benefits it provides the human body.
Max International has acquired all of the assets of CellGevity including:
Herbert T. Nagasawa, Ph.D.: Co-Founder, Chairman and Director of Research
Chief Scientist and co-founder of CellGevity, Inc., Dr. Nagasawa received his B.S. degree in chemistry from Western Reserve University (now, Case-Western Reserve) in Cleveland, Ohio, and the Ph.D. degree in organic chemistry from the University of Minnesota.
Subsequently, he spent two years as a Post-doctoral Fellow in biochemistry at the University of Minnesota before joining the research staff of the V.A. Medical Center in Minneapolis as a Senior Chemist.
He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959.He was named Principal Scientist of the VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA's top scientists.He was promoted to Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973.He also held joint professorships in the Department of Pharmacology and the university-wide Division of Toxicology, and served as Visiting Professor at Washington State University in 1990.He also served for 32 years as a Senior Editor for the prestigious international Journal of Medicinal Chemistry from 1972 to 2004, and one year as Acting Editor-in-Chief.In addition, he served on the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health.
He has published over 165 papers in peer-reviewed journals, and is the inventor named on ten U.S. and PCT patent applications.
...
www.max.com, 11 Feb 2012 [cached]
...
www.effectsofglutathione.com, 5 Mar 2012 [cached]
...
...
Why is Glutathione Reductase is Critical to Our Health by Dr. Nagasawa
www.maxinternational.com, 25 Oct 2012 [cached]
...
Other People with the name "Nagasawa":
Moritex Corporation
Erikson Institute
Johnson & Johnson
DRS Technologies Inc
Other ZoomInfo Searches
Copyright © 2013 Zoom Information, Inc. All rights reserved
Pro2013_Iteration8.31[02] SEIDXWK-21